Educational
Series
L-ArginineM2® |
..................................... |
..................................... |
..................................... |
|
..................................... |
| • |
Ingredient
in Energy Drinks Deemed Dangerous |
..................................... |
| • |
Taurine:
Culprit in Heart Function & Blood Pressure |
..................................... |
| • |
Are
Energy Drinks Safe for the Heart? |
..................................... |
| • |
Skinny
Science Researcher Interviewed by Woman’s World |
..................................... |
| • |
An
Introduction to Skinny Science® Teleseminars |
|
|
 |
L-ArginineM2®
is the only Patented Edible Computer Chip®
that delivers a specific dose of an Arginine molecule
to a targeted delivery site in the human body. |
|
|
The
benefits of any L-Arginine product or formula is based on
its ability to deliver L-Arginine to site-specific-destinations
in the human body, such as:
• |
The
production of Nitric Oxide in elevating serum levels
of Arginine |
• |
L-Arginine
crossing the Blood-Brain-Barrier (BBB) |
• |
Stimulation
of muscle mitochondria |
Essential
to any effective L-Arginine formula, is the ability to deliver
elemental Arginine to targeted sites in the body, utilizing
Threshold Plateau doses.
L-Arginine
benefits are dose and timing-dependent, and reach a Threshold
Plateau at specific elemental doses.
L-ArginineM2®
is the only L-Arginine product on the market that has undergone
25-years of research to determine Arginine human dosing guidelines.
These specific dosing-guidelines are incorporated into every
L-ArginineM2®
product.
|
| • |
Patented
Pharmaceutical-Grade L-Arginine |
| • |
State-of-the-Art
L-Arginine Formulas |
| • |
The
only proven Safe L-Arginine (25 years) |
| • |
L-Arginine
bound to Blind Amino Acid® Riders |
| • |
Patented
L-Arginine for Clinical Trials |
| • |
Patented
L-Arginine Formulas for the Nutraceutical Industry |
| • |
Patented
Nitric Oxide Formulas |
| • |
L-Arginine for Genetic Polymorphisms |
| • |
The
only Certified Low Glycemic L-Arginine |
|
 |
 |
|
About L-Arginine
L-arginine is classified as a conditionally essential amino
acid. In infants, it is essential, due to their inability
to synthesize L-arginine. In adulthood, L-arginine becomes
conditional.
Benefits/Uses
| • |
L-arginine
is the only naturally-occurring amino acid that produces
nitric oxide. |
| • |
Nitric
oxide (NO) is essential to the body for circulatory health.
|
| • |
Nitric
Oxide helps with the elasticity of arterial walls and
increases vasodilation, allowing for better blood flow.
|
| • |
L-arginine
is widely used by athletes to recover from fatigue and
help build muscle mass |
| • |
L-arginine
participates in ammonia removal, cell division and wound
healing. |
Manufacturing
Safe L-Arginine
Safe L-Arginine is manufactured by fermentation
from carbohydrate sources under cGMP conditions. Safe
L-Arginine can be manufactured as a vegetarian formula,
which will not contain any raw materials of animal origin
in the manufacturing process.
High Purity
High
purity means high quality. L-Arginine should
be manufactered as a high purity, pharmaceutical grade L-arginine
made only from vegetable materials.
FDA
A
Drug Master File for L-arginine is on record at the FDA, which
meets USP and EP standards. In the United States, amino acids
are considered dietary supplements. As such, amino acids do
not cure, treat, mitigate, or prevent a disease state or medical
condition. |
|
|
 |
 |
CELLULAR
SIGNALING
WITH NITRIC OXIDE (NO) |
Nitric
Oxide (NO) is synthesized endogenously and plays a central
role in cell-to-cell signaling.
NO is synthesized from L-arginine by the action of nitric
oxide synthases (NOS) in a two-step oxidation process,
with a half-life of a mere 5 seconds.
NO has the ability to cross cellular membranes under
a very fast diffusion rate, and functions as one of
the most primary components of human health.
|
|
The
main issue related to the utilization of NO donors in humans
is based on the fact that most investigators could not envision
how a molecule as toxic as NO could function in a biological
setting. NO functions as both a toxic and non-toxic agent,
depending on its biosynthesis.
NO acts
as a highly reactive, diffusible, and unstable radical under
certain circumstances. Thus, researchers have sought stable
NO donors with potential therapeutic value.
A stable NO donor must be capable of controlling the amount
and rate of NO release in the human body in
order to avoid potential toxic side-effects. The by-products
of a programmed NO-reaction must possess minimal side-effects,
or it cannot be used without danger of negative reactions.
The NO-delivery-dose must be sufficient to induce health benefits
without triggering negative physiological effects. This elemental
dose ranges from 3 grams to 20 grams per day of a NO-donor.
Said doses are appropriate in cases of impotence and fertility.
A targeted-release of NO by a NO-donor requires a Low Glycemic
delivery system that contains a Blind Amino Acid® Rider (BAAR).
The most stable non-drug NO-donor is FF L-Arginine bound to
a BAAR, which is the substrate for nitric oxide synthase.
This form of L-Arginine reverses the inhibition of nitric
oxide synthase caused by arginine analogs, and is proven safe
in humans long-term in doses of 3g - 20g daily. |
|
|
 |
| L-ArginineM2®
is the first L-Arginine complex to contain Embedded Tracer
Technology (ETT). This allows tracking of authentic L-ArginineM2®
products and formulas.
As
an Edible Computer Chip®, L-ArginineM2®
is used as the base of many different Arginine formulas and
products. A Licensing Agreement is required for any use of
L-ArginineM2®
in a product.
Any
formula or product that contains L-ArginineM2®
is required to display the Official L-ArginineM2®
logo on products and attendant marketing literature.
|
|
| |
L-ArginineM2®
has been approved
for use by OLYMPIC AND
PROFESSIONAL ATHLETES
L-ArginineM2®
passes all analytical
protocols for DRUG-FREE Athletes
Click
Here for More Information
|
|
|
